
Acucela Inc.
Get Full AccessDescription
- Acucela Inc. (www.acucela.com or www.acucela.jp) is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucelas proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
-
Headquarters:818 Stewart Street Suite 1110, Seattle, Washington, United States
More -
Phone Number: +1 206-805-8300
-
Website: https://www.acucela.com
-
Employees:32
-
Revenue:$10 - 50M
-
Legal Name:Acucela Inc.
-
Acucela Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 446130 |
Show More
Frequently Asked Questions regarding Acucela Inc.
-
Where are Acucela Inc.'s Headquarters?
Acucela Inc.'s Headquarters are in 818 Stewart Street Suite 1110,Seattle,Washington,United States
-
What is Acucela Inc.'s phone number?
Acucela Inc.'s phone number is +1 206-805-8300
-
What is Acucela Inc.'s official website?
Acucela Inc.'s official website is https://www.acucela.com
-
What is Acucela Inc.'s Revenue?
Acucela Inc.'s revenue is $10 - 50M
-
What is Acucela Inc.'s NAICS code?
Acucela Inc.'s NAICS code is 446130
-
How many employees are working in Acucela Inc.
Acucela Inc. has 32 employees
-
What is Acucela Inc.'s Industry?
Acucela Inc. is in the industry of Biotechnology
-
Who is Acucela Inc.'s Chief Operations Officer?
Acucela Inc.'s Chief Operations Officer is Deborah Kessler